These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31390443)

  • 1. Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Bahia, Brazil.
    Miranda DLP; Ribeiro G; Lanza FC; Santos FLN; Reis RB; Fraga DBM; Silva LK; Silva Neto MMD; Santana IJ; Reis MGD
    Rev Soc Bras Med Trop; 2019 Aug; 52():e20190146. PubMed ID: 31390443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi screening in Texas blood donors, 2008-2012.
    Garcia MN; Woc-Colburn L; Rossmann SN; Townsend RL; Stramer SL; Bravo M; Kamel H; Beddard R; Townsend M; Oldham R; Bottazzi ME; Hotez PJ; Murray KO
    Epidemiol Infect; 2016 Apr; 144(5):1010-3. PubMed ID: 25170765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and epidemiological characteristics of Chagas disease in an endemic area of Sergipe State, Brazil.
    Glass IR; Santos ADD; Varjão AEL; Costa IS; Correia D; Silva ÂM
    Rev Soc Bras Med Trop; 2018; 51(5):660-664. PubMed ID: 30304273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Trypanosoma cruzi antibodies in blood donors from Veracruz State, Mexico.
    Hernández-Romano P; Cámara-Contreras M; Bravo-Sarmiento E; López-Balderas N
    Transfusion; 2015 Mar; 55(3):647-56. PubMed ID: 25208459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).
    Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S
    Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Trypanosoma Cruzi antibodies in blood donors from the Sao Paulo State, Brazil, between 2012 and 2014.
    Slavov SN; Otaguiri KK; Pinto MT; Valente VB; Ubiali EM; Covas DT; Kashima S
    J Infect Dev Ctries; 2017 Mar; 11(3):277-281. PubMed ID: 28368863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the seroprevalence of antibodies against Trypanosoma cruzi among blood donors in a Western Hospital of Venezuela, 2004-2008.
    Herrera-Martínez AD; Rodriguez-Morales AJ
    Acta Trop; 2010 Oct; 116(1):115-7. PubMed ID: 20451488
    [No Abstract]   [Full Text] [Related]  

  • 8. Trypanosoma cruzi: seroprevalence detected in the blood bank of the Instituto Nacional de Pediatría, Mexico City, in the period 2004 through 2009.
    Escamilla-Guerrero G; Martínez-Gordillo MN; Riverón-Negrete L; Aguilar-Escobar DV; Bravo-Lindoro A; Cob-Sosa C; Ponce-Macotela M
    Transfusion; 2012 Mar; 52(3):595-600. PubMed ID: 21880049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi seroprevalence in pregnant women and screening by PCR and microhaematocrit in newborns from Guanajuato, Mexico.
    Montes-Rincón LM; Galaviz-Silva L; González-Bravo FE; Molina-Garza ZJ
    Acta Trop; 2016 Dec; 164():100-106. PubMed ID: 27596439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Trypanosoma cruzi antibody detection in eastern Andalusia (Spain).
    Marín C; Concha-Valdez F; Cañas R; Gutiérrez-Sánchez R; Sánchez-Moreno M
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):165-72. PubMed ID: 24463719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and geographical distribution of sero-positive blood donors to Trypanosoma cruzi at the central blood bank of the National Medical Center "La Raza".
    González-Guzmán S; Paredes-Cervantes V; Bagu ET; Crescencio-Trujillo JA; Guerra-Marquez Á; Rivas N; Alejandre-Aguilar R; Bermúdez-Torres E; González-Cano P
    Transfusion; 2019 Feb; 59(2):639-647. PubMed ID: 30520031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seropositivity for anti-trypanosoma cruzi antibodies among blood donors of the "Hospital Universitário Regional do Norte do Paraná", Londrina, Brazil.
    Reiche EM; Inouye MM; Pontello R; Morimoto HK; Itow Jankevicius S; Matsuo T; Jankevicius JV
    Rev Inst Med Trop Sao Paulo; 1996; 38(3):233-40. PubMed ID: 9163992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors.
    Salles NA; Sabino EC; Cliquet MG; Eluf-Neto J; Mayer A; Almeida-Neto C; Mendonça MC; Dorliach-Llacer P; Chamone DF; Saéz-Alquézar A
    Transfusion; 1996; 36(11-12):969-73. PubMed ID: 8937406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic neonatal screening for congenital Chagas disease in Northeast Brazil: prevalence of Trypanosoma cruzi infection in the Southern region of Sergipe.
    Santos FRD; Euzébio DM; Oliveira GG; Chagas MS; Ferreira AR; Mendonça LA; Correia D; Silva AMD
    Rev Soc Bras Med Trop; 2018; 51(3):310-317. PubMed ID: 29972561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.
    Leiby DA; Herron RM; Read EJ; Lenes BA; Stumpf RJ
    Transfusion; 2002 May; 42(5):549-55. PubMed ID: 12084162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico.
    Sánchez-Guillén MC; Barnabé C; Guégan JF; Tibayrenc M; Velásquez-Rojas M; Martínez-Munguía J; Salgado-Rosas H; Torres-Rasgado E; Rosas-Ramírez MI; Pérez-Fuentes R
    Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):947-52. PubMed ID: 12471419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico.
    Galavíz-Silva L; Molina-Garza DP; González-Santos MA; Mercado-Hernández R; González-Galavíz JR; Rosales-Encina JL; Molina-Garza ZJ
    Am J Trop Med Hyg; 2009 Sep; 81(3):404-6. PubMed ID: 19706904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterogeneous distribution of the prevalence of anti-Trypanosoma cruzi antibodies among blood donors in the State of Puebla, Mexico].
    Monteón VM; Reyes-López PA; Sosa-Palacio A; León-Tello G; Martínez-Murguía J; Sosa-Jurado F
    Salud Publica Mex; 2005; 47(2):116-25. PubMed ID: 15889637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.
    Sabino EC; Lee TH; Montalvo L; Nguyen ML; Leiby DA; Carrick DM; Otani MM; Vinelli E; Wright D; Stramer SL; Busch M;
    Transfusion; 2013 Jun; 53(6):1257-65. PubMed ID: 23002996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.